Praziquantel

Praziquantel structural formula

CAS Number55268-74-1
Molecular FormulaC19H24N2O2
Molecular Weight312.413
InChI KeyFSVJFNAIGNNGKK-UHFFFAOYSA-N
LogP2.35
Synonyms
  • Praziquantel
  • 2-(Cyclohexanecarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
  • 4H-Pyrazino[2,1-a]isoquinolin-4-one, 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-
  • 55268-74-1
  • 5-24-03-00361
  • 4H-Pyrazino[2,1-a]isoquinolin-4-one, 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-
  • (.+-.)-Praziquantel
  • Biltricide
  • Cysticide
  • Distocide
  • Droncit
  • Prazichantel
  • Prazinon
  • Pyquiton
  • BRN 0761557
  • 2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a)isoquinolin-4-one
  • EINECS 259-559-6
  • Praziquantelum
  • UNII-6490C9U457

Applications:

HPLC Chiral Separation of Praziquantel on Cyralis CM Column

June 17, 2026

HPLC Method for Analysis of Praziquantel on Cyralis CM Column by SIELC Technologies

High Performance Liquid Chromatography (HPLC) Method for Analysis of Praziquantel.

Praziquantel is an drug with the chemical formula C19H24N2O2It is primarily used to treat parasitic worm infections in a variety of living beings. In humans, it is used to treat schistosomiasis. tapeworm infections, cysticercosis, and more. It works through increasing the permeability of the membranes of schistosome cells towards calcium ions which leads to contractions of muscles and therefore paralysis of the parasite. You can find detailed UV spectra of Praziquantel and information about its various lambda maxima by visiting the following link.

This application describes a normal-phase chiral HPLC method for the separation of Praziquantel enantiomers using SIELC’s Cyralis CM chiral column. Cyralis CM is a cellulose-based chiral stationary phase (CSP) designed for enantiomeric separations, optical purity testing, chiral impurity analysis, and stereoisomer characterization in pharmaceutical, chemical, agrochemical, and fine chemical applications.

Praziquantel can be retained and analyzed using the Cyralis CM stationary phase column. The analysis utilizes an isocratic method with a mobile phase consisting of Hexane and Ethanol. Detection is performed using UV.

Condition

ColumnCyralis CM, 4.6 x 100 mm, 5 µm, 100 A, dual ended
Mobile PhaseHexane/Ethanol- 70/30%
Flow Rate1.0 mL/min
DetectionUV 230 nm
Resolution2.06

Description

Class of CompoundsDrug
Analyzing CompoundsPraziquantel

Application Column

Cyralis CM

Column Diameter: 4.6 mm
Column Length: 100 mm
Particle Size: 5 µm
Pore Size: 100 A
Column options: dual ended

Add to cart
Application Analytes:
Praziquantel

Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.

UV-Vis Spectrum of Praziquantel

December 24, 2025
Access the UV-Vis Spectrum SIELC Library
UV-Vis Spectrum of Praziquantel.

If you are looking for optimized HPLC method to analyze Praziquantel check our HPLC Applications library

For optimal results in HPLC analysis, it is recommended to measure absorbance at a wavelength that matches the absorption maximum of the compound(s) being analyzed. The UV spectrum shown can assist in selecting an appropriate wavelength for your analysis. Please note that certain mobile phases and buffers may block wavelengths below 230 nm, rendering absorbance measurement at these wavelengths ineffective. If detection below 230 nm is required, it is recommended to use acetonitrile and water as low UV-transparent mobile phases, with phosphoric acid and its salts, sulfuric acid, and TFA as buffers.
For some compounds, the UV-Vis Spectrum is affected by the pH of the mobile phase. The spectra presented here are measured with an acidic mobile phase that has a pH of 3 or lower.

 

 

Application Analytes:
Praziquantel
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.

HPLC Separation of Praziquantel on Legacy L1 Column

July 2, 2013

Condition

Column Primesep 100, 4.6×150 mm, 5 µm, 100A
Mobile Phase MeCN/H2O – 60/40%
Buffer No
Flow Rate 1.0 ml/min
Detection UV, 210 nm

 

Description

Class of Compounds
Drug, Anti-parasite, Hydrophobic, Ionizable
Analyzing Compounds Praziquantel

 

Application Column

SIELC Legacy L1 HPLC column

Legacy L1

SIELC's family of Legacy columns is based on the United States Pharmacopeia's (USP) published chromatographic methods and procedures. Numerous brands have columns used in USP reference standards and methods. USP has created various designations to group together columns with similar types of packing and properties in the solid phase. SIELC's Legacy columns adhere to these strict requirements and properties, allowing you to easily replace older columns that are no longer available without needing to significantly modify your method or SOPs.

Select options

Primesep 100

The Primesep family of mixed-mode columns offers a wide variety of stationary phases, boasting unprecedented selectivity in the separation of a broad array of chemical compounds across multiple applications. Corresponding Primesep guard columns, available with all stationary phases, do not require holders. SIELC provides a method development service available to all customers. Inquire about our specially-tailored custom LC-phases for specific separations.

Select options
Application Analytes:
Praziquantel

Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.